Tracking Smell Loss to Identify Healthcare Workers with SARS-CoV-2 Infection
Authors:
- Julian J. WeissJWJulian J. Weiss
- Tuki N. AttuquayefioTATuki N. Attuquayefio
- Elizabeth B. WhiteEWElizabeth B. White
- Fangyong LiFLFangyong Li
- Rachel S. HerzRHRachel S. Herz
- Theresa L. WhiteTheresa L. White
- Melissa CampbellMCMelissa Campbell
- Bertie GengBGBertie Geng
- Rupak DattaRDRupak Datta
- Anne L. WyllieAWAnne L. Wyllie
- Nathan D. GrubaughNGNathan D. Grubaugh
- Arnau Casanovas-MassanaACArnau Casanovas-Massana
Preprint
- 9 September 2020
- preprint
- Published by Cold Spring Harbor Laboratory in medRxiv
Abstract
Background: Healthcare workers (HCW) treating COVID-19 patients are at high risk for infection and may also spread infection through their contact with vulnerable patients. Smell loss has been associated with SARS-CoV-2 infection, but it is unknown whether monitoring for smell loss can be used to identify asymptomatic infection among high risk individuals, like HCW.Methods: We performed a prospective cohort study, tracking 473 HCW across three months to determine if smell loss could predict SARS-CoV-2 infection in this high-risk group. HCW subjects completed a longitudinal, novel behavioral at-home assessment of smell function with household items, as well as detailed symptom surveys that included a parosmia screening questionnaire, and RT-qPCR testing to identify SARSCoV-2 infection.Results: SARS-CoV-2 was identified in 17 (3.6%) of 473 HCW. Among the 17 infected HCW, 53% reported smell loss, and were more likely to report smell loss than COVID-negative HCW on both the at-home assessment and the screening questionnaire (P< .01). 67% reported smell loss prior to having a positive SARS-CoV-2 test, and smell loss was reported a median of two days before testing positive. Neurological symptoms were reported more frequently among COVID-positive HCW who reported smell loss (P< .01).Conclusions: In this prospective study of HCW, self-reported changes in smell using two different measures were predictive of COVID-19 infection. Smell loss frequently preceded a positive test and was associated with neurological symptoms.Keywords
All Related Versions
- Published version: PLOS ONE, 16 (3), e0248025.
This publication has 39 references indexed in Scilit:
- Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 InfectionJAMA, 2020
- Smell dysfunction: a biomarker for COVID‐19International Forum of Allergy & Rhinology, 2020
- Temporal dynamics in viral shedding and transmissibility of COVID-19Nature Medicine, 2020
- Presumed Asymptomatic Carrier Transmission of COVID-19JAMA, 2020
- Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional StudyClinical Infectious Diseases, 2020
- The Influence of Circadian Timing on Olfactory SensitivityChemical Senses, 2017
- Evaluating the clinical usefulness of structured questions in parosmia assessmentThe Laryngoscope, 2010
- Accuracy of Self‐Report in Detecting Taste DysfunctionThe Laryngoscope, 2008
- Valid across-group comparisons with labeled scales: the gLMS versus magnitude matchingPhysiology & Behavior, 2004
- Labeled scales (e.g., category, Likert, VAS) and invalid across-group comparisons: what we have learned from genetic variation in tasteFood Quality and Preference, 2003